Open Access Open Access  Restricted Access Subscription Access

Utility of Pap Smear Screening for Prevention of Cervical Cancer-A 3yrs Study from Rural Tripura-A Northeastern State of India


Affiliations
1 Department of Obstetrics and Gynaecology, Khowai District Hospital, India
2 Department of Pathology, TMC and DR BRAM Teaching Hospital, India
 

Background: Cancer cervix is a leading cause of mortality and morbidity among women worldwide. According to National Cancer Registry Program of India, cancers of cervix and breast are leading malignancies in Indian women. The morbidity and mortality could be significantly reduced with an active cervical smear screening programme.

Objective: The study was done to evaluate the knowledge and attitudes of women about cervical smear testing, to establish a cervical smear screening program and to evaluate the cervical cytological abnormalities. It was done to determine the applicability, limitations and utility of this screening in a district hospital.

Materials and Methods: A total of 287 married women were included in our study. Knowledge about Pap smear testing was determined through printed questionnaires. Pap smear screening was performed on every woman in our study group. Detailed clinical data and cytology reports were noted in a proforma.

Results: About 92% women of our study group had never heard or undergone Pap smear screening before. Maximum number of patients was in 4th decade. Of the 287 smears, 276(96.16%) were adequate. Normal smear were 78(27.18%), inflammatory 168(58.54%), whereas epithelial cell abnormalities were seen in 26(9.05%) cases. The 26 abnormal cases comprised of 17(5.92%) cases with ASCUS, 5(1.74%) cases of LSIL, 1(0.35%) cases of HSIL, 3(1.04%) cases of squamous cell carcinoma.

Conclusions: Epithelial cell abnormality in our study group was less than Western countries. There is poor knowledge about Pap smear screening. Pap smear study can be easily done through a chain built between the primary health care unit and district hospital and laboratory.


Keywords

Pap Smear, Cervical Smear, Cervical Intraepithelial Lesion, Cervical Cancer, Cervical Cancer Screening, Bethesda System.
User
Notifications
Font Size


  • de Martel C, Ferlay J, Franceschi S, Vignat J, Bray F, Forman D, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012;13:607-15.
  • Rejendra A Kalkar, Yogesh Kulkarini. Screening for cervical cancer: an overview. Obstet Gynecol India 2006 March / April;56(2):115-22.
  • Mohammed Shaoaib Khan, Fohadiya Yasin Raja, Gazala Ishfaq, Faheem Tahir, Fazli Subhan, Birjees Mazhar Kazi, et al. Pap smear Screening for Precancerous conditions of the cervical cancers. Pak J Med Res 2005;44(3):111-3.
  • Shanta V, Krishnamurthi S, Gajalakshmi CK, Swaminathan R, Ravichandran K. Epidemiology of cancer of cervix: Global and national perspective. J Indian Med Assoc 2000;98:49-52.
  • A Juneja, A Sehgal, S Sharma, Pandey A. Cervical cancer screening in India: Strategies revisited. Indian J Med Sci 2007;61:34-47.
  • Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55:74-108.
  • Indian council of medical research. National Cancer Regitry Program. India. Three-Year Report of Population Based Cancer Registries 2012-2014: NCDIR-NCRP(ICMR);2016 March Available from: URL: http://www.icmr.nic.in
  • Indian council of medical research. National Cancer Regitry Program. Tripura. Five year report 2010-2014 Population based cancer registry, Tripura: PBCR, Tripura, Regional Cancer Centre, Agartala;2016 June.
  • Cheryl LR, Clair WM, Kevin R, Mack TR. Prevention of cervical cancer. Critical review in Oncology /Hematology 2000;33:169-185.
  • Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JMA 2002 Apr 24;287(16):2114-9.
  • Saslow D, Solomon D, Lawson H, Killackey M, Kulasingam S, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. Journal of Lower Genital Tract Disease 2012;16(3):175-204.
  • Richart RM. A modified terminology for Cervical Intraepithelial Neoplasia. Obst Gynecol 1990;75:131-3.
  • Pradhan B, Pradhan SB, Mital VP. Correlation of Pap smear findings with clinical findings and cervical biopsy. Kathmandu University Medical Journal 2007;5(20):461-7.
  • Solomon D, Nayar R. The Bethesda System for Reporting Cervical Cytology: Definitions, Criteria, and Explanatory Notes. 2nd ed. New York: Springer Science & Business Media; 2004.
  • Bishop A. Shessis TS. Cervical dysplasia treatment: Key issues for developing countries. Bull Pan Am Health Organ 1996;30:378-86.
  • Sunita A, Bamanikar, Dadaso S. Baravkar, Shirish S. Chandanwale. Study of Cervical Pap Smears in a Tertiary Hospital. Indian Medical Gazette 2014;16(3):250-4.
  • Ranabhat SK, Shrestha R, Tiwari M. Analysis of abnormal epithelial lesions in cervical Pap smears in Mid-Western Nepal.Journal of Pathology of Nepal 2011;1:30-3.
  • Remzi Atilgan, Aygen Celik, Abdullah Boztosun, Erdin Ilter, Tulin Yalta, Resat Ozercan. Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Micr 2012;55(1):52-5.
  • Turkish Cervical Cancer And Cervical Cytology Research Group: Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009;106:206-9.
  • Patel MM, Pandya AN, Modi J. Cervical papsmear study and its utility in cancer screening, to specify the strategy for cervical cancer control. National Journal of Community Medicine 2011;2(1):49-51.
  • Ghaith JE, Rizwana BS. Rate of Opportunistic Pap smear Screening and Patterns of Epithelial Cell Abnormalities in Pap Smears in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J 2012;12(4):473-8.

Abstract Views: 252

PDF Views: 115




  • Utility of Pap Smear Screening for Prevention of Cervical Cancer-A 3yrs Study from Rural Tripura-A Northeastern State of India

Abstract Views: 252  |  PDF Views: 115

Authors

Debashis Saha
Department of Obstetrics and Gynaecology, Khowai District Hospital, India
Sumana Ghosh
Department of Pathology, TMC and DR BRAM Teaching Hospital, India
Sanjay Nath
Department of Pathology, TMC and DR BRAM Teaching Hospital, India
Habibul Islam
Department of Pathology, TMC and DR BRAM Teaching Hospital, India

Abstract


Background: Cancer cervix is a leading cause of mortality and morbidity among women worldwide. According to National Cancer Registry Program of India, cancers of cervix and breast are leading malignancies in Indian women. The morbidity and mortality could be significantly reduced with an active cervical smear screening programme.

Objective: The study was done to evaluate the knowledge and attitudes of women about cervical smear testing, to establish a cervical smear screening program and to evaluate the cervical cytological abnormalities. It was done to determine the applicability, limitations and utility of this screening in a district hospital.

Materials and Methods: A total of 287 married women were included in our study. Knowledge about Pap smear testing was determined through printed questionnaires. Pap smear screening was performed on every woman in our study group. Detailed clinical data and cytology reports were noted in a proforma.

Results: About 92% women of our study group had never heard or undergone Pap smear screening before. Maximum number of patients was in 4th decade. Of the 287 smears, 276(96.16%) were adequate. Normal smear were 78(27.18%), inflammatory 168(58.54%), whereas epithelial cell abnormalities were seen in 26(9.05%) cases. The 26 abnormal cases comprised of 17(5.92%) cases with ASCUS, 5(1.74%) cases of LSIL, 1(0.35%) cases of HSIL, 3(1.04%) cases of squamous cell carcinoma.

Conclusions: Epithelial cell abnormality in our study group was less than Western countries. There is poor knowledge about Pap smear screening. Pap smear study can be easily done through a chain built between the primary health care unit and district hospital and laboratory.


Keywords


Pap Smear, Cervical Smear, Cervical Intraepithelial Lesion, Cervical Cancer, Cervical Cancer Screening, Bethesda System.

References





DOI: https://doi.org/10.18311/ijmds%2F2017%2F149896